SG/PUT/ASTRAZENECA/12000/0.1/20.09.24 Stock

DE000SW9N9R1

Real-time Boerse Frankfurt Warrants 06:07:35 2024-07-16 am EDT
0.51 ^EUR	+13.33%

Current month	+4.65%
1 month	+9.76%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart ASTRAZENECA PLC

Chart SG/PUT/ASTRAZENECA/12000/0.1/20.09.24

Latest news about ASTRAZENECA PLC

Global markets live: Airbus, Burberry, AT&T, Boeing, Vinfast...	Jul. 15
AstraZeneca : Acquisition of Amolyt Pharma completed Form 6 K	Jul. 15	PU
AstraZeneca: acquisition of Amolyt Pharma finalized	Jul. 15	CF
AstraZeneca Closes $1.05 Billion Amolyt Pharma Acquisition	Jul. 15	MT

More news

Quotes 5-day view

Date	Price	Change
24-07-16	0.51	+13.33%
24-07-15	0.45	+9.76%
24-07-12	0.41	-19.61%
24-07-11	0.51	+2.00%
24-07-10	0.5	-13.79%

Real-time Boerse Frankfurt Warrants

Last update July 16, 2024 at 06:07 am EDT

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	PUT
Underlying	ASTRAZENECA PLC
Issuer	Société Générale
WKN	SW9N9R
ISIN	DE000SW9N9R1
Date issued	2024-04-29
Strike	12,000 p
Maturity	2024-09-20 (67 Days)
Parity	10 : 1
Emission price	0.75 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	0.74 €
Lowest since issue	0.34 €
Spread	0.01 €
Spread %	1.92%

Company Profile

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).

Sector

More about the company